
Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death
Keywords: AMR; Antibody-mediated Rejection; CDC; Complement Dependant Cytotoxicity; cPRA; Calculated Panel Reactive Antibody; DSA; Donor Specific Antibodies; HB-MFI; Highest bead MFI; DGF; Delayed Graft Function; BPAR; Biopsy Proven Acute Rejection; MFI; Mean Fluor